Nosocomial transmission of Serratia marcescens in a veterinary hospital due to contamination by benzalkonium chloride.

Journal of Clinical Microbiology
J G FoxG W Thornton

Abstract

During a 1-year period, Serratia marcescens was isolated from 50% of all contaminate intravenous catheters from dogs and cats in a large veterinary hospital. S. marcescens was also isolated from respiratory tracts, genitourinary tracts, skin, and other sites in hospitalized animals. A total of 55% of the clinical isolates and 66% of the intravenous catheter isolates had the same API biochemical profile. The source of the S. marcescens was determined to be aqueous benzalkonium chloride (0.025%) sponge pots located in the intensive care unit, surgery rooms, and outpatient clinic areas of the hospital. Of the 11 S. marcescens isolates submitted to the Centers for Disease Control for serotyping (6 from aqueous benzalkonium chloride sponge pots, 5 from intravenous catheters), 8 were identified as serotype O10:H11. All S. marcescens isolates tested for antibiotic susceptibilities were multiply resistant; isolates were most frequently resistant to streptomycin, cephalothin, and ampicillin. This study demonstrates that improper use of disinfectants plays an important role in the nosocomial transmission of S. marcescens.

References

Aug 28, 1976·Lancet·J J FarmerR A Bobo
Jul 1, 1976·The Journal of Pediatrics·W E StammH R de Quinones
Jun 1, 1976·Journal of Clinical Microbiology·S J RubinR W Lyons
Jul 1, 1975·Anesthesiology·J R WaltonB E Reisberg
Apr 1, 1973·The Journal of Small Animal Practice·R J Wilkins
Nov 1, 1973·The Journal of Infectious Diseases·D G MakiJ V Bennett
Aug 8, 1968·The New England Journal of Medicine·J N WilfertE H Kass
Jul 1, 1970·Annals of Internal Medicine·C V SandersJ P Sanford
Sep 5, 1970·The Veterinary Record·E A Wijewanta, M Fernando
Dec 1, 1957·A.M.A. Archives of Surgery·R B KUNDSIN, C W WALTER
Jun 1, 1958·The American Journal of the Medical Sciences·S A PLOTKIN, R AUSTRIAN
Jun 4, 1959·The New England Journal of Medicine·M D SHICKMANM L PEARCE
Sep 9, 1961·JAMA : the Journal of the American Medical Association·J C LEE, P J FIALKOW
Oct 20, 1960·The New England Journal of Medicine·W F MALIZIAA F GOLEY

❮ Previous
Next ❯

Citations

Jul 1, 1984·Equine Veterinary Journal·S Shaftoe
Apr 6, 2007·Biological & Pharmaceutical Bulletin·Fereshteh ShahcheraghiTomofusa Tsuchiya
Feb 12, 2011·Journal of the American Animal Hospital Association·Cristina PerezEdward Breitschwerdt
Jan 23, 2014·BMC Infectious Diseases·Günter KampfChristiane Ostermeyer
Apr 10, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tejpratap S P TiwariRichard J Wallace
Oct 3, 2007·Antimicrobial Agents and Chemotherapy·David J WeberEmily E Sickbert-Bennett
May 8, 2013·Journal of Veterinary Internal Medicine·A C DavenportE B Breitschwerdt
Aug 10, 2013·Infection Ecology & Epidemiology·Tisha A M HarperAbiodun A Adesiyun
Apr 15, 2018·Applied and Environmental Microbiology·Minjae KimKonstantinos T Konstantinidis
Mar 10, 2004·The Veterinary Record·J JoresA Lübke-Becker
Aug 17, 2001·Veterinary Microbiology·P BoerlinP Schawalder
Oct 17, 2002·The Veterinary Clinics of North America. Small Animal Practice·Justine A Johnson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.